Katheterinterventionelle Therapie
bei peripherer arterieller Verschlusskrankheit und diabetischer
Angiopathie

S Werth; K Halbritter; A Mahlmann; N Weiss

doi:10.1055/s-0031-1286378

DMW – Klinischer Fortschritt, Table of Contents

Dtsch Med Wochenschr 2011; 136(40): 1994-1997
DOI: 10.1055/s-0031-1286378

Angiologie | Commentary

Angiologie
© Georg Thieme Verlag KG Stuttgart · New York

Katheterinterventionelle Therapie bei peripherer arterieller Verschlusskrankheit und diabetischer Angiopathie

Interventional treament of peripheral arterial disease and diabetic angiopathyS. Werth¹ , K. Halbritter¹ , A. Mahlmann¹ , N. Weiss¹

¹Universitäts GefäßCentrum und Medizinische Klinik III, Bereich Angiologie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden

Abstract

Schlüsselwörter

periphere arterielle Verschlusskrankheit - kritische Extremitätenischämie - perkutane transluminale Angioplastie

Keywords

peripheral arterial disease - critical limb ischemia - percutaneous transluminal angioplasty

Full Text

References

Literatur

1 Anononymus .TASC guidelines set to recommend „endovascular first” for all lesions. http://www.cxvascular.com letzter Zugriff 30.8.2011
2 Biondi-Zoccai G G, Sangiorgi G, Lotrionte M. et al . Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009; 16 251-260
3 Bosiers M, Deloose K, Callaert J, Keirse K, Verbist J, Peeters P. Drug-eluting stents below the knee. J Cardiovasc Surg. 2011; 2 231-234
4 Bosiers M, Kallakuri S, Deloose K, Verbist J, Peeters P. Infragenicular angioplasty and stenting in the management of critical limb ischaemia: one year outcome following the use of the MULTI-LINK VISION stent. EuroIntervention. 2008; 3 470-474
5 Bosiers M, Lioupis C, Deloose K. et al . Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia. Vascular. 2009; 17 1-8
6 Commeau P, Barragan P, Roquebert P O. Sirolimus for below the knee lesions: mid- term results of SiroBTK study. Catheter Cardiovasc Interv. 2006; 5 793-798
7 Deloose K, Bosiers M, Peeters P. One year outcome after primary stenting of infrapopliteal lesions with the Chromis Deep stent in the management of critical limb ischaemia. EuroIntervention. 2009; 5 318-324
8 DeRubertis B G, Pierce M, Ryer E J. et al . Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg. 2008; 47 101-108
9 Doraswami U. Is the DESTINY of drug-eluting stents below the knee?. http://www.cxvascular.com letzter Zugriff 31.8.2011
10 Ferraresi R, Centola M, Ferlini M. et al . Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2009; 37 336-342
11 Gregg E W, Sorlie P, Paulose-Ram R. et al . Prevalence of lower-extremity disease in the US adult population ( 40 years of age with and without diabetes: 1999 – 2000 national health and nutrition examination survey. Diabetes Care. 2004; 27 1591-1597
12 Giles K A, Pomposelli F B, Spence T L, Hamdan A D, Blattman S B, Panossian H, Schermerhorn M L. Population-based outcomes of open descending thoracic aortic aneurysm repair. J Vasc Surg. 2008; 48 128-136
13 Ingle H, Nasim A, Bolia A. et al . Subintimal angioplasty of isolated infragenicular vessels in lower limb ischemia: long-term results. J Endovasc Ther. 2002; 9 411-416
14 Joviliano E E, Piccinato C E, Dellalibera-Joviliano R. et al . Inflammatory Markers and Restenosis in Peripheral Percutaneous Angioplasty With Intravascular Stenting: Current Concepts. Ann Vasc Surg. 2011, May 28; [epub ahead of print] DOI: 10.1016/j.avsg.2011.02.026
15 Kudo T, Chandra F A, Ahn S S. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg. 2005; 41 423-435
16 Müller-Hülsbeck S. Rekanalisation am Unterschenkel: PTA oder Stent?. Radiologe. 2010; 50 23-28
17 Norgren L, Hiatt W R, Dormandy J A. et al . Inter-Society Consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007; 33 Suppl 1 S1-75
18 Nowygrod R, Egorova N, Greco G. et al . Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg. 2006; 43 205-216
19 Scheinert D, Ulrich M, Scheinert S, Sax J, Bräunlich S, Biamino G. Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention. 2006; 2 169-174
20 Siablis D, Karnabatidis D, Katsanos K. et al . Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol. 2009; 20 1141-1150
21 Siablis D, Kraniotis P, Karnabatidis D, Kagadis G C, Katsanos K, Tsolakis J. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia. J Endovasc Ther. 2005; 6 685-695
22 Zeller T, Schmitmeier S, Tepe G, Rastan A. Drug-coated balloons in the lower limb. J Cardiovasc Surg. 2011; 2 235-243

Prof. Dr. Norbert Weiss

Universitäts GefäßCentrum und Medizinische Klinik III
Bereich Angiologie
Universitätsklinikum Carl Gustav Carus
an der Technischen Universität Dresden

Fetscherstr. 74

01307 Dresden

Email: norbert.weiss@uniklinikum-dresden.de